Effect of Idelalisib in follicular lymphoma monocultures and cocultured with follicular dendritic cells (FDC)

ABSTRACT: Follicular Lymphoma primary cells (FL) were treated with the PI3K delta inhibitor idelalisib (500nM, 48h) in the presence or absence of follicular dendritic cells We used microarrays to uncover the mechanisms underlying mechanism of resistance and sensitivity of FL to idelalisib

ORGANISM(S): Homo sapiens

PROVIDER: GSE130918 | GEO | 2020/09/15

REPOSITORIES: GEO